Summary
Malignant pericardial effusion is usually treated only when signs of cardiac tamponade develop. Several methods of treatment have been reported with an overall response rate of approximately 75%. Since our initial study using intrapericardial 32P-colloid instillation as a treatment modality for pericardial effusion demonstrated a significant higher response rate, this study was conducted to further evaluate the efficacy of intrapericardial 32P-colloid in terms of response rates and duration of remissions. Intrapericardial instillation of 185–370 MBq (5–10 mCi) 32P-colloid in 36 patients with malignant pericardial effusion resulted in a complete remission rate of 94.5% (34 patients) whereas two patients did not respond to treatment due to a foudroyant formation of pericardial fluid. The median duration time was 8 months. No side-effects were observed. These results suggest that intrapericardial instillation of 32P-colloid is a simple, reliable and safe treatment strategy for patients with malignant pericardial effusions. Therefore, since further evidence is provided that 32P-colloid is significantly more effective than external radiation or non-radioactive sclerosing agents, this treatment modality should be considered for the management of malignant pericardial effusion.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Buck, M., Ingle, J. N. & Guilani, E. R. (1987). Pericardial effusion in women with breast cancer. Cancer 60: 263–270.
Campbell, P. T., Van Tright, P. & Wall, T. C. (1992). Subxiphoid pericardiotomy in the diagnosis and management of large pericardial effusions associated with malignancy. Chest 101: 938–945.
Cham, W. C., Freiman, A. H. & Carstens, P. H. B. (1975). Radiation therapy of cardiac and pericardial metastases. Ther Radiol 114: 701–707.
Clarke, T. H. (1952). Radioactive colloidal gold198 in the treatment of neoplastic effusions. Northwest U Med School Q Bull 26: 98–103.
Colleoni, M., Martinelli, G., Beretta, F., Marone, C., Gallino, A., Fontana, M., Graffeo, R., Zampino, G., De Pas, T., Cipolla, G., Martinoni, C. & Goldhirsch, A. (1998). Intracavitary chemotherapy with thiotepa in malignant pericardial effusions: an active and well-tolerated regimen. J Clin Oncol 16: 2371–2376.
DeLoach, J. F. & Haynes, J. W. (1953). Secondary tumors of heart and peritoneum: review of the subject and report of 137 cases. Arch Intern Med 91: 224–230.
Firusian, N. (1980). 32 P-therapy for malignant pericardial effusion. Onkologie 3: 12–17
van der Gaast, A., Kok, T. C., Hoogerbrugge, N. & van der Linden, T. A. W. (1989). Intrapericardial instillation of bleomycin in the management of malignant pericardial effusion. Eur J Cancer Clin Oncol 25: 1505–1506.
Hancock, E. W. (1979). Management of pericardial disease. Mod Concepts Cardiovasc Dis 48: 1–12.
Harbert, J. C. (1997). Radiocolloid therapy of malignant pericardial effusion. In Principles of Nuclear Medicine, Harbert JC (ed), Lippincott: Philadelphia 1077–1082.
Martini, N., Freiman, A. H. & Watson, R. C. (1977). Intrapericardial instillation of radioactive chromic phosphate in malignant pericardial effusion. Am J Roentgenol 128: 639–644.
Mills, S. A., Holiday, R. A. & Vinten-Johansen, J. M. (1989). Subxiphoid pericardial window for pericardial effusive disease. J Cardiovasc Surg 30: 768–773.
Nowrousian, M. R., Firusian, N. & Schmidt, C. G. (1988). Diagnostik und Therapie maligner Perikardergüsse. Beitr Onkol 33: 114–144.
Shenkai, T., Tomenagu, K. & Saijo, N. (1982). The incidence of cardiac metastases in primary lung cancer and the management of malignant pericardial effusion. Jpn J Clin Oncol 12: 23–28.
Shepherd, F. A., Ginsberg, J. S., Evans, W. K., Scott, J. G. & Oleksiuk, F. (1985). Tetracycline sclerosis in the management of malignant pericardial effusion. J Clin Oncol 3: 1678–1682.
Skhvatsabaju, L. V. (1986). Secondary malignant lesions of the heart and pericardium in neoplastic disease. Oncology 43: 103–109.
Smith, F. E., Lane, M. & Hudgins, P. T. (1974). Conservative management of malignant pericardial effusion. Cancer 33: 47–56.
Terry, L. N. & Klegerman, M. M. (1970). Pericardial and myocardial involvement by lymphomas and leukemias: the role of radiotherapy. Cancer 25: 1003–1010.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Dempke, W., Firusian, N. Treatment of malignant pericardial effusion with 32P-colloid. Br J Cancer 80, 1955–1957 (1999). https://doi.org/10.1038/sj.bjc.6690625
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690625
Keywords
This article is cited by
-
Pericardial fluid: an underrated molecular library of heart conditions and a potential vehicle for cardiac therapy
Basic Research in Cardiology (2019)
-
A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811)
British Journal of Cancer (2009)
-
Akuttherapie onkologischer Notfälle
Intensivmedizin und Notfallmedizin (2007)